Evaluating the Utility of Bone Grafts in Open Wedge Corrective Osteotomy and Plate Fixation

NCT ID: NCT06093763

Last Updated: 2024-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

INTRODUCTION A variety of bone grafts and substitutes are available for filling bone defects in the distal radius after corrective osteotomy, but the harvesting of bone from the iliac crest is the gold standard as it allows easy access to corticocancellous bone of a desirable quality and quantity. The idea behind bone grafting is to provide optimal bone formation and structural stability, which is crucial for bone healing. However, the harvesting and use of bone from the iliac crest potentially comes with the risk of complications such as delayed union of the osteotomy defect; size mismatch between the graft and the osteotomy defect; longer operation time; donor site morbidity including nerve, arterial, and ureteral injury; herniation of abdominal contents; sacroiliac joint instability; pelvic fractures; hematoma and infection. As these disadvantages of bone grafting can have a major impact on patients' everyday lives, research is needed on whether bone grafting is genuinely necessary during corrective osteotomy and plate fixation of the distal radius

OBJECTIVE The objective of this study is to investigate whether harvested bone graft from the iliac crest necessary is during corrective osteotomy and plate fixation in patients with malunited distal radius fractures.

STUDY DESIGN This is a prospective, randomized, controlled multicenter study. Patients will undergo the following examinations once before the operation and five times afterwards: 1) the patients will fill out three questionnaires, 2) complications will be noted, 3) the wrist function will be measured, and 4) radiographs/CT scans will be made.

STUDY POPULATION All patients over the age of 18 years who have a symptomatic malunion after distal radius fracture and are eligible for surgical correction.

INTERVENTION Surgical correction in the form of open wedge corrective osteotomy and plate fixation without bone grafting.

USUAL CARE Open wedge corrective osteotomy and plate fixation with harvesting bone from the iliac crest.

OUTCOME MEASURES Primary outcomes: complications and quality of life. Secondary outcomes: time to complete bone healing, functional outcomes, and cost effectiveness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malunion of Fracture of Radius

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

All included patients will undergo an open wedge osteotomy and plate fixation according to the standard surgical techniques. In one group, the bone defect will be filled with bone graft of the iliac crest after open wedge osteotomy according the standard procedure. The other group includes patients who will not receive any bone grafts. The participating hospitals have extensive experience with both treatments.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
A web based randomisation tool will used for randomization according to the GCP-guidelines. Prestratification per hospital will be performed. Patients and the treating surgeon cannot be blinded for the treatment because a part of these patients will undergo bone grafting derived from the iliac crest. The statistician will be blinded for the treatment.

6.3 Study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with symptomatic malunion of distal radius receiving bone grafting

Open wedge corrective osteotomy and plate fixation with harvesting and using bone from the iliac crest.

Group Type ACTIVE_COMPARATOR

Group with bone grafting

Intervention Type PROCEDURE

Open wedge corrective osteotomy and plate fixation with harvesting and using bone from the iliac crest.

Patients with symptomatic malunion of distal radius receiving none bone grafts

Open wedge corrective osteotomy and plate fixation without harvesting and using bone from the iliac crest.

Group Type ACTIVE_COMPARATOR

Group without bone grafting

Intervention Type PROCEDURE

Open wedge corrective osteotomy and plate fixation without bone grafting.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group without bone grafting

Open wedge corrective osteotomy and plate fixation without bone grafting.

Intervention Type PROCEDURE

Group with bone grafting

Open wedge corrective osteotomy and plate fixation with harvesting and using bone from the iliac crest.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of either sex over the age of 18 years
* Symptomatic malunion of the distal radius
* Eligible for open wedge osteotomy and plate fixation with or without bone grafting from iliac crest.
* Patients are able to undergo postoperative follow-up of at least 12 months.

Exclusion Criteria

* Patients who are pregnant
* Patients who have known systemic or metabolic disorders leading to progressive bone deterioration
* Patients who take chronic use of glucocorticoids.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Haga Hospital

OTHER

Sponsor Role collaborator

Amsterdam UMC

OTHER

Sponsor Role collaborator

VieCuri Medical Centre

OTHER

Sponsor Role collaborator

Zuyderland Medical Centre

OTHER

Sponsor Role collaborator

Elkerliek Hospital

OTHER

Sponsor Role collaborator

Erasmus Medical Center

OTHER

Sponsor Role collaborator

Amphia Hospital

OTHER

Sponsor Role collaborator

Reinier Haga Orthopedisch Centrum

OTHER

Sponsor Role collaborator

Flevoziekenhuis

OTHER

Sponsor Role collaborator

Diakonessenhuis, Utrecht

OTHER

Sponsor Role collaborator

Xpert Clinics

UNKNOWN

Sponsor Role collaborator

Maastricht University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pascal Hannemann, MD

Role: PRINCIPAL_INVESTIGATOR

Maastricht University Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MaastrichtUMC

Maastricht, Zuid-Limburg, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dominique Disseldorp, MD

Role: CONTACT

0031433877489

Fabienne Hameleers

Role: CONTACT

0031433877489

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dominique Disseldorp, MD

Role: primary

0031433877489

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL68126.068.18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.